Radiopharmaceutical Market Will Grow at a Cagr of 8.8% from 2015 to 2020

Published By:Zion Market Research

Radiopharmaceutical Market by Type (Diagnostic Radiopharmaceuticals and Therapeutic
radiopharmaceuticals), for Cardiology, Neurology, Oncology and Other Applications- Global
Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast,
2015 – 2021

Contact Us:
4283, Express Lane, Suite 634-143,
Sarasota, Florida 34249, United States
Tel: +1-386-310-3803 GMT
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

sales@zionmarketresearch.com

Radiopharmaceutical Market

Zion Research has published a new report titled “Radiopharmaceutical Market by Type (Diagnostic
Radiopharmaceuticals and Therapeutic radiopharmaceuticals), for Cardiology, Neurology, Oncology and
Other Applications- Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment,
Trends and Forecast, 2015 – 2021”. According to the report, global demand for radiopharmaceutical market
was valued at around USD 4.32 billion in 2015, is expected to reach approximately USD 7.13 billion in 2021
growing at a CAGR of more than 8.8% between 2016 and 2021.
Radiopharmaceutical is a medication used in nuclear medicine that has radioactive part and pharmaceutical
part. Nuclear medication is given to a patient in a small amount; this makes patient body radioactive for short
time span. A special nuclear medicine camera detects the radiation emitted from the body, and takes images
on inner body organs to check its function. Most of the radiopharmaceuticals used in diagnostic nuclear
medicine procedures emit gamma radiation. The most commonly used gamma emitting radionuclide in
nuclear medicine is 99mTechnetium, which is labeled to different types of pharmaceuticals to formulate
diagnostic imaging agent’s i.e radiopharmaceuticals.
Browse the full "Radiopharmaceutical Market by Type (Diagnostic Radiopharmaceuticals and
Therapeutic radiopharmaceuticals), for Cardiology, Neurology, Oncology and...